Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39059194/
Accurate information about locoregional treatments in breast cancer neoadjuvant systemic therapy (NST) trials is vital to support surgical decision-making and allow meaningful interpretation of long-term oncological outcomes. This systematic review...
This systematic review highlights poor and inconsistent reporting of locoregional treatment outcomes in breast cancer neoadjuvant systemic therapy studies, emphasizing the need for a core outcome set and reporting guidelines.
Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39216449/
Breast cancer (BC) is one of the most frequently diagnosed cancers in women. Chemotherapy continues to be the treatment of choice for clinically combating it. Nevertheless, the chemotherapy process is...
This article reviews multidrug resistance (MDR) mechanisms in breast cancer and explores nano-drug delivery systems (NDDS) as potential solutions to improve chemotherapy efficacy and overcome MDR challenges.
Cryotherapy in the Treatment of Early-Stage Breast Cancer
Source : https://pubmed.ncbi.nlm.nih.gov/39328333/
Breast cancer is one of the most common malignancies, affecting millions of people worldwide annually. The treatment paradigm for early-stage breast cancer is in flux. The focus is now on...
Cryoablation shows promise as a minimally invasive treatment for early-stage breast cancer, with ongoing trials crucial for assessing its safety and effectiveness compared to traditional surgical approaches.
Breast cancer immunotherapy: Realities and advances
Source : https://pubmed.ncbi.nlm.nih.gov/39308754/
Breast cancer (BC) is the most common malignant tumor and the main cause of death in women worldwide. With increased knowledge regarding tumor escape mechanisms and advances in immunology, many...
Immunotherapy shows promise in breast cancer treatment, but challenges like resistance and modest response rates persist, requiring ongoing clinical trial evaluations and optimization for improved efficacy in combination with standard therapies.
Triple-negative breast cancer treatment with core-shell Magnetic@Platinium-Metal organic framework/epirubicin nano-platforms for chemo-photodynamic based combinational therapy: A review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39331917/
The combination of chemotherapy and photodynamic therapy (PDT), enabled by core-shell nano-platforms, is a promising method to improve cancer therapy by overcoming hypoxia and boosting drug penetration in breast tumor....
The M@Pt-MOF/EPI nano-platform enhances cancer treatment through effective chemo-photodynamic therapy, improving drug delivery and therapeutic efficacy in various cancers, particularly triple-negative breast cancer.